Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 2 analysts offering 12 month price targets for Ascletis Pharma Inc have a median target of 2.91, with a high estimate of 3.81 and a low estimate of 2.00. The median estimate represents a 190.56% increase from the last price of 1.00.
High | 281.1% | 3.81 |
Med | 190.6% | 2.91 |
Low | 100.0% | 2.00 |
Earnings history & estimates in CNY
Average growth rate | -18.06% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +3.70% |
More ▼